Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

EGX:PHAR Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,554	6,829	5,430	3,621	4,155	4,309
Market Cap Growth	25.78%	25.78%	49.96%	-12.86%	-3.57%	-34.63%
Enterprise Value	15,491	14,578	9,630	5,388	5,509	5,532
Last Close Price	50.78	43.17	32.68	23.71	25.05	24.17
PE Ratio	6.89	6.23	6.60	5.63	8.52	8.86
Forward PE	8.31	7.03	5.92	5.77	6.23	7.52
PS Ratio	1.00	0.90	1.04	0.92	1.22	1.49
PB Ratio	1.62	1.47	1.27	1.12	1.40	1.51
P/TBV Ratio	1.63	1.48	1.28	1.12	1.40	1.52
P/OCF Ratio	-	-	58.71	-	10.83	26.14
PEG Ratio	-	4.15	4.15	4.15	4.15	4.15
EV/Sales Ratio	2.04	1.92	1.84	1.36	1.62	1.92
EV/EBITDA Ratio	8.84	9.12	7.33	7.10	6.35	7.61
EV/EBIT Ratio	9.37	9.70	7.95	8.14	7.09	9.42
EV/FCF Ratio	-3.76	-	-	-	-	-
Debt / Equity Ratio	1.98	1.98	1.15	0.88	0.59	0.63
Debt / EBITDA Ratio	5.76	5.76	3.74	3.76	2.03	2.47
Asset Turnover	0.60	0.60	0.63	0.66	0.66	0.61
Inventory Turnover	1.46	1.46	1.36	1.21	1.08	1.03
Quick Ratio	0.45	0.45	0.65	0.54	0.67	1.02
Current Ratio	1.38	1.38	1.94	1.72	2.13	2.13
Return on Equity (ROE)	24.60%	24.60%	21.95%	20.71%	16.78%	16.81%
Return on Assets (ROA)	7.41%	7.41%	9.04%	6.89%	9.46%	7.77%
Return on Capital (ROIC)	8.14%	8.14%	9.90%	7.63%	10.36%	8.53%
Return on Capital Employed (ROCE)	15.80%	15.80%	16.90%	16.10%	21.70%	17.70%
Earnings Yield	14.51%	16.04%	15.14%	17.76%	11.74%	11.29%
FCF Yield	-54.55%	-60.34%	-40.48%	-23.75%	-1.28%	-0.90%
Dividend Yield	2.96%	3.48%	3.06%	4.22%	5.99%	-
Payout Ratio	39.61%	39.61%	37.67%	61.14%	78.64%	103.41%
Buyback Yield / Dilution	-	-	-50.00%	-	-1.64%	1.61%
Total Shareholder Return	2.96%	3.48%	-46.94%	4.22%	4.35%	1.61%

Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.